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reduced number of blood vessels feeding
the tumors in the embryos injected with
the proteins. The tumors actually regressed
and the embryos developed normally. In
the control embryos, the blood vessels pro-
liferated in their usual pattern, promoting
the growth ofthe tumors.
"The research is very promising and has
great potential," says James Pluda, an angio-
genesis expert at the National Cancer
Institute in Bethesda, Maryland. The exper-
iment designed by the Scripps researchers
"approaches disrupting the angiogenic path-
way at a point that is different than other
[studies have shown]," says Pluda.
"We're excited about having it
progress," says Pluda, who oversees the
development of anti-angiogenic drugs at
NCI. "It's very interesting; it's also very
preliminary," he cautions. The proteins
could lead to unwanted side effects in
other tissue, which could inhibit wound
healing, for example, or possibly lead to
fetal damage in pregnant women.
At this stage of research, scientists at
Ixsys are completing toxicology studies to
determine the extent, if any, of adverse
effects of the LM609 antibody. They will
also perform tests to rule out any biological
properties that would discourage the use of
the antibody in humans.
According to Brooks, the Scripps
research team duplicated their chick-
embryo test results in experiments on small
sections of human skin grafted onto mice
and observed a twofold reduction in tumor
size. Their laboratory findings held true for
a broad range of solid-tumor human can-
cers, including malignant melanomas and
cancers ofthe lung, breast, pancreas, brain,
and larynx.
According to Brooks, the team collabo-
rated with another Scripps researcher, oph-
thalmologist Martin Friedlander, and dis-
covered that the protein therapy may be
useful in treating several eye disorders as
well, including diabetic retinopathy and
macular degeneration.
Elusive EMFs
Do electric and magnetic fields (EMFs)
cause cancer? Researchers still don't know
for sure, since the latest epidemiological
look at EMF health effects contradicts
some previous findings.
The new study, conducted by epidemi-
ologist David A. Savitz ofthe University of
North Carolina-Chapel Hill School of
Public Health, underscores the need to
identify biological mechanisms associated
with EMF health effects, NIEHS officials
say.
Savitz, whose work in 1988 helped
spark intense public and scientific debate
over the safety of EMFs, now concedes
that future investiga-
tions must identify
"biologically relevant
exposure metrics." If
properly defined, he
adds, epidemiological
studies may still shed
light on EMF effects.
"I hate to give up
on epidemiology out-
right, but I think that
it needs to evolve," says
Savitz. "We need
either more innovative
epidemiological studies
or biological studies."
In his newly pub-
lished review of
138,905 male utility
workers, men exposed
to high-level 60-Hertz
magnetic fields were
about twice as likely to
develop brain cancer,
although they devel-
oped only about 70% as many brain
tumors as expected. Nonetheless, men sub-
jected to extremely high-level fields experi-
enced 2.6 times greater risk than the aver-
age American, Savitz reported with co-
author Dana Loomis in the American
JournalofEpidemiolog (vol. 141, no. 2).
Yet, Savitz found no link between mag-
netic fields and leukemia, except among
electricians. This finding is puzzling when
compared with other recent studies.
A 1993 report by J.D. Sahl and col-
leagues failed to identify any statistically
significant link between magnetic fields
and brain cancer or leukemia among
36,000 workers at the Southern California
Edison Company. Another study of
223,292 Canadian and French utility
workers, published in 1994 by Gilles
Theriault and associates, offered no con-
vincing evidence ofan increased brain-can-
cer risk among highly exposed groups.
Unlike Savitz, however, Theriault reported
that exposed individuals were up to three
times more likely to develop certain
leukemias.
Savitz was instrumental in launching
numerous epidemiological studies of EMF
effects. In 1988, he published a case-con-
trol study of 356 childhood cancer cases
whose findings seemed to confirm a 1979
study byepidemiologist NancyWertheimer
and physicist Ed Leeper. Among 344
Denver-area children, they reported, those
dwelling within 49 to 131 feet of high-
power electricity lines were two to three
times more likely to die ofcancers.
Despite 16 years of subsequent
research, however, the debate over EMFs
continues. In his latest study, Savitz care-
fully ruled out the effects of two other
Power thinker. David Savitz is among those researchers moving to mecha-
nistic studies of EMFs.
workplace carcinogens: polychlorinated
biphenyls (PCBs) and solvents. But he
could not account for many other variables
such as cigarette smoking among test sub-
jects or magnetic fields within homes.
Researcher Philip Cole of the
University of Alabama at Birmingham
questions Savitz's interpretation of the
EMF data. Among 138,905 workers, brain
cancer and nervous system cancers claimed
the lives of 151 men: 8 fewer deaths than
expected. In an unpublished evaluation of
the Savitz study, Cole says this finding is in
fact "negative, or at most weakly positive."
But Savitz says utility workers tend to be
healthier than the average American. "It's a
pretty well-established phenomenon that
working populations have lower mortalities
from a whole range ofcauses," he says.
Future studies must account for more
complex variables, says Wertheimer. Many
researchers believe that EMFs may work
cooperatively with other carcinogens to
promote tumor development, she notes.
Overall, the body of epidemiological
research thus far suggests a relatively small
increase in cancer risks (1.5 to 2.5 times
greater) for those exposed to high-level
magnetic fields, according to Savitz.
"Savitz has done the best job possible,"
Wertheimer continues. "But we still don't
know if [his test subjects] used electric
blankets or lived in high-exposure neigh-
borhoods. We still have avery blunt tool."
Attempts to hone that tool are being
made using toxicological and basic biologi-
cal studies as the focus of an EMF health
effects research program directed by the
NIEHS and administered by the U.S.
Department ofEnergy.
"It didn't make sense for us to fund
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additional epidemiological research," says
Dan VanderMeer, NIEHS director of the
Office of Program Planning and Evalu-
ation. "We decided to focus on those
health conditions that have been identified
in epidemiological studies."
Dubbed EMF RAPID, for Electric and
Magnetic Fields Research and Public
Information Dissemination, the program
was authorized by Congress in October
1992. Over a five-year period, Congress
authorized up to $65 million to support
research and public information. The law
also calls for matching private funds.
Using animal models, EMF RAPID
grant recipients are testing epidemiological
findings related to leukemia, breast cancer,
brain tumors, and other diseases,
VanderMeer reports. In addition, molecu-
lar and cellular studies are addressing possi-
ble biological mechanisms, including
immune-system suppression, direct or
indirect DNA changes, disruption ofcellu-
lar communications, and impacts on mela-
tonin, a hormone that blocks tumor for-
mation in vitro.
EMF RAPID funds were also used to
expand an existing NIEHS animal study
conducted as part of the National
Toxicology Program. At the IIT Research
Institute (IITRI), a 21,000-square-foot
laboratory makes it possible to expose
2,400 animals to magnetic fields under
highly controlled conditions, says Gary
Boorman, chiefofthe Pathology Branch in
the NIEHS Environmental Toxicology
Program. Principal investigator David L.
McCormick of IITRI exposes rats and
mice to magnetic fields to assess reproduc-
tive, immunological, and carcinogenic
effects, as well as melatonin levels.
In all studies, researchers are trying to
replicate robust effects, says Michael
Galvin, a general physiologist at NIEHS.
"An effect that appears only once and is
not robust enough to be replicated consis-
tently or demonstrates a so-called Cheshire
cat effect would be difficult to assess,"
Galvin notes.
Wertheimer worries that NIEHS
researchers may fail to identify a health
hazard because they are focusing on
whether EMFs initiate tumors. In fact, she
says, EMFs may promote cancer develop-
ment only when tumors are initiated by
some other agent. "The idea of direct
DNA damage is still foremost in their
minds," Wertheimer says of NIEHS offi-
cials. "I don't think that's what we're deal-
ing with here." However, according to
VanderMeer, NIEHS is also supporting
mechanistic studies ofpossible EMF effects
on cell signaling, cell membrane function,
tissue and organ systems, and free radicals.
"These mechanisms," says VanderMeer,
"are important irrespective of whether
EMFs may act as direct or indirect carcino-
gens.
The NIEHS decided to emphasize
tumor initiation because research groups in
Canada, Sweden, and Germanywere already
investigating co-promotion effects, Boorman
says. But, he adds, EMF RAPID funds will
support two co-promotion studies at IITRI.
Using genetically engineered rodents with a
known cancer susceptibility, McCormick's
team will assess whether EMFs speed tumor
development among animals exposed to car-
cinogens such as diethylnitrosamine. Plans
for additional promotion studies using a rat
breast cancer model are also being developed
at NIEHS.
Chemical Weapons: Safe
until 2004?
In a December 1994 report, the General
Accounting Office questioned an Army
assessment that the U.S. chemical weapons
stockpile can be safely stored until 2004.
This is Congress's latest deadline for the
Department of Defense to destroy stock-
piled unitary chemical weapons-those
that contain a single lethal agent.
Of concern are 478,000 M55 rockets
stored at sites in five states and on
Johnston Atoll in the Pacific Ocean.
According to GAO and technical consul-
tant Sandia National Laboratories in
Albuquerque, New Mexico, these stock-
piled M55 rockets are unstable as stored
and inadequately monitored by the Army,
the Department of Defense's lead service
in chemical matters.
Initially, Congress directed the De-
partment of Defense to destroy M55s and
the rest of the stockpile by 30 September
1994. When the Army fell behind in
Chemical Stockpile Munitions and Locations
Storage site Weapons Agents stored
Aberdeen Proving Ground, Maryland Ton container H
Anniston Army Depot, Alabama Projectiles and cartridges H, GB, VX
M23 mine VX
Ton container H, GB
M55 rocket GB, VX
Blue GrassArmy Depot, Kentucky Projectiles and cartridges H, VX
Ton container H, GB
M55 rocket GB, VX
Johnston Atoll Projectiles and cartridges H, GB, VX
M23 mine VX
Ton container H, GB, VX
M55 rocket GB
Bomb GB
Newport Ammunition Plant, Indiana Ton container VX
Pine BluffArsenal, Arizona M23 mine VX
Ton container H
M55 rocket GB, VX
Pueblo Army Depot, Colorado Projectiles and cartridges H
Ton container H
Tooele Army Depot, Utah Projectiles and cartridges H, GB, VX
M23 mine VX
Bomb GB
Spray tank VX
Ton container H, GB, VX
M55 rocket GB, VX
Umatilla DepotActivity, Oregon Projectiles and cartridges GB, VX
M23 mine VX
Bomb GB
Spray tank VX
Ton container H, GB, VX
M55 rocket GB, VX
The chemical munitions stockpile is located at eight sites in the continental United
States and on Johnston Atoll in the Pacific Ocean. Aberdeen Proving Ground and
NewportArmyAmmunition Plant store only bulk agent. SOURCE: Chemical Weapons,
Stability ofthe U.S. Stockpile, GAO, December 1994.
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